Early angiotensin converting enzyme inhibitor therapy after experimental myocardial infarction prevents left ventricular dilation by reducing infarct expansion: A possible mechanism of clinical benefits

Coronary Artery Disease

Volumn 9, Issue 12, 1998, Pages 815-821

  Ali, Shaik M ^a   Brown Jr , Edward J ^a   Nallapati, Sreenivasa R ^a   Alhaddad, Imad A ^a  

^a BRONX LEBANON HOSPITAL CENTER   (United States)

Author keywords

Infarct expansion; Left ventricular dilation; Left ventricular remodeling; Myocardial infarction

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; HEART LEFT VENTRICLE VOLUME; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL RATE;

EID: 0032420834     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199809120-00006     Document Type: Article

References (35)

1. Hutchins GM, Bulkley BH. Infarct expansion versus extension: two different complications of acute myocardial infarction. Am J Cardiol 1978; 41:1127-1132.
2. Hochman JS, Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 1987; 75:299-306.
3. Alhaddad IA, Kloner RA, Hakim I, Garno JL, Brown EJ Jr. Benefits of late coronary artery reperfusion on infarct expansion progressively diminish over time: relationship to viable islets of myocytes within the scar. Am Heart J 1996; 131:451-457.
4. Alhaddad IA, Tkaczevski L, Siddiqui F, Mir R, Brown EJ Jr. Aspirin enhances the benefits of late reperfusion on infarct shape. A possible mechanism of the beneficial effects of aspirin on survival after acute myocardial infarction. Circulation 1995; 91:2819-2823.
5. LATE Study Group. Late assessment of thrombolytic efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 1993; 342:759-766.
6. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous Streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988, ii:349-360.
7. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group: ISIS-4. A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995; 345:669-685.
8. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343:1115-1122.
9. Ambrosioni E, Borghi C, Magnani B, for the Survival of Myocardial Infarction Long-term Evaluation (SMILE) study investigators: The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 1995; 332:80-85.
10. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, on behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival And Ventricular Enlargement trial. N Engl J Med 1992; 327:669-677.
11. St John Sutton M, Pfeffer MA, Plappert T, Rouleau JL, Moye LA, Dagenais GR, et al., for the SAVE Investigators. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation 1994; 89:68-75.
12. Weisman HF, Bush DE, Mannisi JA, Bulkley BH. Global cardiac remodeling after acute myocardial infarction: a study in the rat model. J Am Coll Cardiol 1985; 5:1355-1362.
13. Jeremy RW, Allman KC, Bautovitch G, Harris PJ. Patterns of left ventricular dilation during the six months after myocardial infarction. J Am Coll Cardiol 1989; 13:304-310.
14. Warren SE, Royal HD, Markis JE, Grossman W, McKay RG. Time course of left ventricular dilation after myocardial infarction: influence of infarctretated artery and success of coronary thrombolysis. J Am Coll Cardiol 1988; 11:12-19.
15. Brown EJ Jr, Swinford RD, Gadde P, Lillis O. Acute effects of delayed reperfusion on myocardial infarct shape and left ventricular volume. A potential mechanism of additional benefits from thrombolytic therapy. J Am Coll Cardiol 1991; 17:1641-1650.
16. Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, Stewart D, et al., for the SOLVD (Studies of Left Ventricular Dysfunction) investigators. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. Circulation 1992; 86:431-438.
17. Fishbein MC, Maclean D, Maroko PR. Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 1978; 90:57-70.
18. Eaton LW, Weiss JL, Bulkley BH, Garrison JB, Weisfeldt ML. Regional cardiac dilatation after acute myocardial infarction: recognition by two-dimensional echocardiography. N Engl J Med 1979; 300:57-62.
19. Hirayama A, Adachi T, Asada S, Mishima M, Nanto S, Kusuoka H, et al. Late reperfusion for acute myocardial infarction limits the dilatation of left ventricle without the reduction of infarct size. Circulation 1993; 88:2565-2574.
20. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342:821-828.
21. Kober L, Torp-Pederson C, Carlsen JE, Bagger H, Eliasen P, Lyngborg KK. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995; 333:1670-1676.
22. Ertl G, Kloner RA, Alexander RW, Braunwald E. Limitation of experimental infarct size by an angiotensin-converting-enzyme inhibitor. Circulation 1982; 65:40-48.
23. Bussman WD, Micke G, Hildenbrand R, Klepzig H Jr. Captopril in acute myocardial infarction: beneficial effects on infarct size and arrhythmias. Clin Cardiol 1995; 18:465-470.
24. Mancini GB, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENndothelial Dysfunction) Study. Circulation 1996; 94:258-265.
25. Sahgal P, Brown EJ Jr, Tkaczevski L, Muia N Jr, Mir R, Alhaddad IA. Early ACE inhibitor therapy enhances the benefits of late coronary artery reperfusion on infarct expansion [abstract]. J Am Coll Cardiol 1997; 29:493.
26. Baily RG, Lehman JC, Gubin SS, Musch TI. Non invasive assessment of ventricular damage in rats with myocardial infarction. Cardiovasc Res 1993; 27:851-855.
27. Burrell CM, Char R, Phillips PA, Calafiori P, Tonkin AM, Johnston CT. Validation of an echocardiographic assessment of cardiac function following moderate size myocardial infarction in rats. Clin Exp Pharmacol Physiol 1996; 23:570-572.
28. Schulman SP, Weiss JL, Becker LC, Guerci AD, Shapiro EP, Chandra NC, et al. Effect of early enalapril therapy on left ventricular function and structure in acute myocardial infarction. Am J Cardiol 1995; 76:764-770.
29. Hale SL, Kloner RA. Left ventricular topographic alterations in the completely healed rat infarct caused by early and late coronary artery reperfusion. Am Heart J 1988; 116:1508-1513.
30. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 1985; 57:84-95.
31. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 1985; 72:406-412.
32. Topol EJ, Califf RM, Vandormael M, Grines CL, George BS, Sanz ML, ef al., and the Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group. A randomized trial of late reperfusion therapy for acute myocardial infarction. Circulation 1992; 85:2090-2099.
33. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilation after anterior myocardial infarction. N Engl J Med 1988; 319:80-86.
34. GISSI-3 Investigators. Causes of early in-hospital mortality of patients with acute myocardial infarction: the impact of ACE-inhibitor treatment [abstract]. Circulation 1995; 92:1-673.
35. Schuster EH, Bulkley BH. Expansion of transmural myocardial infarction: a pathophysiologic factor in cardiac rupture. Circulation 1979; 60:1532-1538.